Look for better financials,and be careful trusting what you read on boards.Product growth and brand trust at MSLP is stupid good, and they have moved forward with great, however complicated steps to clean the books. They can have no debt fairly soon with the low estimates of growth projected.People have lots of reasons to bash stocks.Read and make your own decisions.This one could Hurt real bad if released too soon. MSLP
"Retiring the convertible debt has helped reduce uncertainty in our equity structure and represents a major step in our plan to re-capitalize MusclePharm and strengthen its balance sheet. We are very excited to have completed this program and to continue our focus on growing our business, and adding value for our shareholders." "We are pleased to have reduced our derivative liability exposure on the company's balance sheet," said John Bluher, chief operating officer. "A significant amount of the company's operating loss and dilution to shareholders was attributable to these convertible note instruments. While such debt served a purpose during a time when we were investing in marketing and branding with the objective of creating revenues, we are happy to be moving ahead without these toxic dilutive instruments."